Over a 32 month period, the OPAT service received 781 patient referrals, of which 243 were not accepted, most commonly (158, 65%) owing to infection specialist assessment that iv antimicrobials were not indicated, including the availability of oral alternatives (Table S1, available as Supplementary data at JAC Online). Consequently, we present data from 538 patients resulting in 544 episodes of OPAT patient care. The median age was 57 (IQR 39–71) years, 60% of the cohort was male and 13% had diabetes mellitus. The median duration of an OPAT care episode was 7 days (IQR 2–18), but was dependent on the OPAT indications, the commonest being skin and soft tissue infections (32% of episodes) (Table S2). The three most frequent antimicrobials used were ceftriaxone, teicoplanin and ertapenem (Table S3) and midline catheters accounted for over half the total indwelling iv catheter duration (Table S4). Overall, OPAT was judged to be a full/partial success in 93% of episodes. A total of 35 patients (6.4%) required readmission and there were two deaths (0.4%).

Table 1.

Antimicrobial- and iv catheter-related OPAT AEs

Usage (no. of episodes)AEs, N (%)aAE rate per 1000 days (95% CI)b
Antimicrobial drugs usedantimicrobial drug-relatedantimicrobial drug-related
 all antimicrobials68813 (1.9)1.7 (0.9–2.9)
  β-lactam antimicrobials51710 (1.9)1.7 (0.2–12.3)
  non-β-lactam antimicrobials1713 (1.8)1.2 (0.4–3.6)
iv catheters usediv catheter-relatediv catheter-related
 all catheters57632 (5.6)5.7 (4.2–7.9)
  non-radiologically guided midline catheters11823 (19.5)15.6 (10.3–23.4)
  radiologically guided midline catheters15521 (13.5)0.67 (0.43–1.02)
  PICC327 (21.9)0.45 (0.19–1.1)
  peripheral cannulae2613 (1.1)2.38 (0.77–7.4)
  tunnelled central venous line catheters100 (0)
Method of OPAT drug administrationiv catheter-relatediv catheter-related
 self-administration308 (27)12.0 (6.0–23.9)
 mixed administration204 (20)8.5 (3.3–23.5)
 nurse-administered48827 (5.5)4.8 (3.3–7.0)
Usage (no. of episodes)AEs, N (%)aAE rate per 1000 days (95% CI)b
Antimicrobial drugs usedantimicrobial drug-relatedantimicrobial drug-related
 all antimicrobials68813 (1.9)1.7 (0.9–2.9)
  β-lactam antimicrobials51710 (1.9)1.7 (0.2–12.3)
  non-β-lactam antimicrobials1713 (1.8)1.2 (0.4–3.6)
iv catheters usediv catheter-relatediv catheter-related
 all catheters57632 (5.6)5.7 (4.2–7.9)
  non-radiologically guided midline catheters11823 (19.5)15.6 (10.3–23.4)
  radiologically guided midline catheters15521 (13.5)0.67 (0.43–1.02)
  PICC327 (21.9)0.45 (0.19–1.1)
  peripheral cannulae2613 (1.1)2.38 (0.77–7.4)
  tunnelled central venous line catheters100 (0)
Method of OPAT drug administrationiv catheter-relatediv catheter-related
 self-administration308 (27)12.0 (6.0–23.9)
 mixed administration204 (20)8.5 (3.3–23.5)
 nurse-administered48827 (5.5)4.8 (3.3–7.0)
a

AE percentages as a proportion of the number of episodes of use for each variable.

b

AE rates per 1000 days of OPAT care, unadjusted for other variables.

Table 1.

Antimicrobial- and iv catheter-related OPAT AEs

Usage (no. of episodes)AEs, N (%)aAE rate per 1000 days (95% CI)b
Antimicrobial drugs usedantimicrobial drug-relatedantimicrobial drug-related
 all antimicrobials68813 (1.9)1.7 (0.9–2.9)
  β-lactam antimicrobials51710 (1.9)1.7 (0.2–12.3)
  non-β-lactam antimicrobials1713 (1.8)1.2 (0.4–3.6)
iv catheters usediv catheter-relatediv catheter-related
 all catheters57632 (5.6)5.7 (4.2–7.9)
  non-radiologically guided midline catheters11823 (19.5)15.6 (10.3–23.4)
  radiologically guided midline catheters15521 (13.5)0.67 (0.43–1.02)
  PICC327 (21.9)0.45 (0.19–1.1)
  peripheral cannulae2613 (1.1)2.38 (0.77–7.4)
  tunnelled central venous line catheters100 (0)
Method of OPAT drug administrationiv catheter-relatediv catheter-related
 self-administration308 (27)12.0 (6.0–23.9)
 mixed administration204 (20)8.5 (3.3–23.5)
 nurse-administered48827 (5.5)4.8 (3.3–7.0)
Usage (no. of episodes)AEs, N (%)aAE rate per 1000 days (95% CI)b
Antimicrobial drugs usedantimicrobial drug-relatedantimicrobial drug-related
 all antimicrobials68813 (1.9)1.7 (0.9–2.9)
  β-lactam antimicrobials51710 (1.9)1.7 (0.2–12.3)
  non-β-lactam antimicrobials1713 (1.8)1.2 (0.4–3.6)
iv catheters usediv catheter-relatediv catheter-related
 all catheters57632 (5.6)5.7 (4.2–7.9)
  non-radiologically guided midline catheters11823 (19.5)15.6 (10.3–23.4)
  radiologically guided midline catheters15521 (13.5)0.67 (0.43–1.02)
  PICC327 (21.9)0.45 (0.19–1.1)
  peripheral cannulae2613 (1.1)2.38 (0.77–7.4)
  tunnelled central venous line catheters100 (0)
Method of OPAT drug administrationiv catheter-relatediv catheter-related
 self-administration308 (27)12.0 (6.0–23.9)
 mixed administration204 (20)8.5 (3.3–23.5)
 nurse-administered48827 (5.5)4.8 (3.3–7.0)
a

AE percentages as a proportion of the number of episodes of use for each variable.

b

AE rates per 1000 days of OPAT care, unadjusted for other variables.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close